SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
power to decide
'Unconscionable': Trump Admin Blasted for Plan to Ban Abortions at VA Hospitals
"Those who fight for all our freedom must have the most basic freedom to control their own bodies and futures—and this rule robs them of it," said the head of Planned Parenthood Federation of America.
Aug 04, 2025
Advocates for veterans, reproductive rights campaigners, and Democrats in Congress on Monday continued to lambaste the Trump administration's quiet move to end abortion care for former U.S. service members and their relatives.
"Since taking office, the Trump administration has repeatedly attacked service members, veterans, and their families' access to basic reproductive care, including gender-affirming care," said Planned Parenthood Federation of America president and CEO Alexis McGill Johnson in a Monday statement.
Planned Parenthood and its leader have frequently criticized actions by President Donald Trump, including his signature on Republicans' recently passed budget reconciliation package that targets the group's clinics—which provide a range of healthcare services—by cutting them off from Medicaid funds if they continue to offer abortions.
"Those who fight for all our freedom must have the most basic freedom to control their own bodies and futures—and this rule robs them of it. Taking away access to healthcare shows us that the Trump administration will always put politics and retribution over people's lives," McGill Johnson said of the new proposal for veterans' care. "Planned Parenthood will never stop fighting to ensure everyone has access to the full spectrum of sexual and reproductive healthcare—no matter what."
The Trump Administration just moved to BAN abortion care for VETERANS, even in instances of rape and incest.This is just another attack on our veterans and reproductive health care.We owe it to our servicemembers to provide them the care they need.
[image or embed]
— Rep. Ted Lieu (@reptedlieu.bsky.social) August 4, 2025 at 1:06 PM
In the wake of the U.S. Supreme Court's 2022 reversal of Roe v. Wade, the Biden administration allowed the Department of Veterans Affairs to provide abortion counseling and care for service members and beneficiaries in cases of rape, incest, or if the pregnancy threatened the health of the patient. On Friday, the VA proposed a rule that would "reinstate the full exclusion on abortions and abortion counseling from the medical benefits package," and the Civilian Health and Medical Program.
The document says the VA would continue treating ectopic pregnancies and miscarriages, and would allow abortion care "when a physician certifies that the life of the mother would be endangered if the fetus were carried to term."
The proposal quickly drew rebuke from a range of critics, including U.S. lawmakers. Blasting the proposed rule as "disgusting and dangerous," Senate Veterans' Affairs Committee Ranking Member Richard Blumenthal (D-Conn.) said on social media Friday that the government "should not be able to impose a pregnancy on anyone—least of all survivors of rape, abuse, or those whose health is at risk."
Sen. Patty Murray (D-Wash.), who had advocated for the Biden administration's policy, declared Saturday that "Republicans don't care if your health is in danger, if you're a veteran, or if you've been raped—they want abortion outlawed everywhere, for everyone."
As the 30-day public comment period for the proposed rule began Monday, U.S. House Veterans' Affairs Committee Ranking Member Mark Takano (D-Calif.) warned that "stripping away access to essential reproductive healthcare at VA, the largest integrated healthcare network in the United States, puts veterans' lives at risk and violates the promise we made to them. Veterans have earned the right to healthcare. Full stop. This ban on reproductive healthcare will harm veterans and is dangerous."
The proposal makes clear that VA Secretary Doug Collins "is substituting his judgment for that of the hundreds of thousands of women veterans who have earned the freedom to make personal medical decisions in consultation with their providers," Takano said in a statement. "It also gags medical providers and does not allow them to provide complete and honest care to veterans who get their care from VA. Rolling back this rule is a direct attack on veterans' rights. It will jeopardize the lives of pregnant veterans across our country, especially those residing in states with total abortion bans and other reproductive healthcare restrictions, which have already led to preventable deaths."
Reproductive rights advocates have similarly weighed in over the past few days and highlighted the anti-choice state laws enacted since the Dobbs v. Jackson Women's Health Organization decision reversed Roe.
Katie O'Connor, senior director of federal abortion policy at the National Women's Law Center, said that "at a time when extremist lawmakers are passing cruel abortion bans and restrictions, this move only deepens the crisis those laws have created—stripping veterans of their reproductive freedom and creating even more confusion about where they can turn for care."
"Veterans already face unique challenges to their health and well-being, including experiencing PTSD, recovering from military sexual trauma, and facing an increased risk of suicide," she noted, referring to post-traumatic stress disorder. "Banning access to the full range of reproductive services, including abortion, further jeopardizes their health and safety. No one should have to travel hundreds of miles, endure financial hardship, or risk their health just to get the medical care they need. Our veterans deserve better."
Center for Reproductive Rights president and CEO Nancy Northup declared that "this administration is sending a clear message to veterans—that their health and dignity aren't worth defending. To devalue veterans in this way and take away life-changing healthcare would be unconscionable. This shows you just how extreme this administration's anti-abortion stance is—they would rather a veteran suffer severely than receive an abortion."
Dr. Raegan McDonald-Mosley, a practicing OB-GYN and CEO of Power to Decide, also warned that the new "needlessly cruel policy change," if it goes through as expected, will harm veterans and "once again betrays our nation's commitment to them."
"Since the Supreme Court overturned Roe v. Wade, 12 states have enacted total abortion bans, one additional state has no abortion clinics, and seven states have gestational restrictions often in effect so early that people don't even know they are pregnant," she explained. "All of this exacerbates an ongoing public health crisis. For some veterans, VA was the only place they were able to obtain abortion care in these states."
"Restrictions on abortion coverage—the effects of which fall hardest on people who already face unequal access to healthcare, including Black women, people of color, and people with low incomes—hinder a person's reproductive well-bring and deepen inequities," the doctor added. "Power to Decide condemns this policy and urges Congress to pass legislation to ensure all veterans have access to the abortion care they need when and where they need it."
Keep ReadingShow Less
Abortion Rights Defenders 'Sound the Alarms' Over RFK Jr. Attack on Mifepristone
"Hawley is pointing to new junk science to motivate RFK Jr. and FDA to review the science on mifepristone," said one public health scientist. "The science is clear: Mifepristone is safe."
May 15, 2025
Abortion rights defenders and scientists expressed deep concern after U.S. Health and Human Services Secretary Robert F. Kennedy Jr.'s remarks about mifepristone, a key medication used to end pregnancies, at a Wednesday congressional hearing.
During the Senate Health, Education, Labor and Pensions Committee hearing, Sen. Josh Hawley (R-Mo.) inquired about the secretary's previous pledge to conduct "top-to-bottom review" of mifepristone, asking, "Do you continue to stand by that and don't you think that this new data shows that the need to do a review is, in fact, very pressing?"
Kennedy, one of President Donald Trump's most controversial Cabinet picks, responded by describing the data cited by Hawley as "alarming," suggesting that "the label should be changed," and confirming that he has asked Marty Makary, commissioner of the Food and Drug Administration (FDA), "to do a complete review and to report back."
Ushma Upadhyay, a public health scientist and professor at the University of California, San Francisco, posted the exchange on social media. She said that "Hawley is pointing to new junk science," and research has made clear "mifepristone is safe."
Hawley is pointing to new junk science to motivate RFK Jr. and FDA to review the science on mifepristone. I've been studying #abortion safety for a decade. The science is clear: mifepristone is safe. Let me tell you about a couple of **peer-reviewed and published** studies I've done... 🧪
[image or embed]
— Ushma Upadhyay, PhD, MPH ( @ushma.bsky.social) May 14, 2025 at 9:20 PM
In one study of Upadhyay's studies, "among 11,000 medication abortions, less than a third of one percent (0.3%) had a serious adverse event," the expert noted. In another from last year, she continued, "we found that telehealth abortion was just as safe and effective as published estimates of in-person care. Serious adverse events were 0.25%."
However, anti-abortion groups have seized on the paper cited by Hawley—published in April by the think tank Ethics & Public Policy Center—to pressure the Trump administration to restrict mifepristone further, or even remove it from the market.
The April paper conflicts with a mountain of research. A 2023 New York Times review found that "more than 100 scientific studies, spanning continents and decades, have examined the effectiveness and safety of mifepristone and misoprostol, the abortion pills that are commonly used in the United States. All conclude that the pills are a safe method for terminating a pregnancy."
Upadhyay said Wednesday that "one crappy report cannot silence decades of peer-reviewed high-quaility published research."
Other critics of RFK Jr.'s comments similarly stressed medical conclusions about mifepristone's safety.
"Mifepristone has a 25-year record of safety and efficacy under the FDA's watch, but now anti-abortion extremists are peddling junk science in an effort to deny people access to it," the group Power to Decide said on social media Thursday. "The reality is that medication abortion is safe, widely used basic healthcare."
The Center for Reproductive Rights also responded on social media, declaring, "SOUND THE ALARMS!"
"Let us be clear: President Trump, who once suggested injecting bleach, should not be making decisions about our healthcare, and RFK Jr. should not be interfering with our ability to access medication that's been PROVEN SAFE AND EFFECTIVE," the center said. "In putting this target on mifepristone—and therefore on abortion access at large—Trump's administration is making it clear that they do not care about science, or our health and safety. They only care about taking away our rights. But we refuse to let that happen."
"We'll be in court on Monday, fighting to protect mifepristone and make sure this VITAL, LIFESAVING medication is accessible and available to anyone who needs it," the center added, referring to oral arguments for Whole Woman's Health Alliance v. FDA, a case aimed at eliminating restrictions that impede access to mifepristone.
The ACLU pointed out in a Wednesday statement that the "pseudo-science paper" at the center of Hawley and Kennedy's exchange echoes calls made in Project 2025—a Heritage Foundation-led guide for a far-right overhaul of the federal goverment, from which Trump unsuccessfully tried to distance himself on the campaign trail—to severely restrict access to medication abortion.
"Secretary Kennedy just revealed that he has ordered the FDA to consider making it harder for people to get medication abortions based on propaganda pushed out by a Project 2025 sponsor," said Julia Kaye, senior staff attorney for the ACLU's Reproductive Freedom Project. "Even leading anti-abortion advocates admit this junk science is 'not a study in the traditional sense,' and is 'not conclusive proof of anything,' but that clearly won't stop extremist politicians from waving it around as a basis to restrict abortion."
"We should all be scared if our access to safe, FDA-approved medications turns on President Trump's gut instinct rather than credible scientific evidence," she warned. "This new FDA review has nothing to do with science and everything to do with teeing up nationwide restrictions on abortion."
Kaye added that "if the FDA moves forward with this politically motivated review, that is a dangerous sign that the president is going back on his promises to voters not to restrict abortion access even further."
Keep ReadingShow Less
After Panel Recommendation, Groups Say FDA Must Approve OTC Birth Control 'Without Delay'
"Every day we wait is another day longer where barriers remain in place, preventing people from getting access to the contraceptive care they want and need," said one leading OTC birth control advocacy coalition.
May 11, 2023
Reproductive rights groups on Wednesday called on the Food and Drug Administration to approve a birth control pill for over-the-counter use "without any further delay" after an advisory panel unanimously recommended permitting use of the medication without a prescription—two decades after advocates first began campaigning on the issue.
A joint advisory committee voted 17-0 in favor of offering OPill, which was first approved for prescription use 50 years ago, without a prescription after hearing from public health analysts and scientists. Concerns that some FDA scientists raised about patients failing to take birth control correctly unless they were provided the pills by a medical professional were outweighed by the benefits, the panel found.
"The panel expresses confidence in the effectiveness, not only in the general population of females, but also in adolescent populations and those with limited literacy," Maria Coyle, chairwoman of the committee, told The New York Times. "The panel seems very comfortable with the limited number of risks from the medication itself."
The Free the Pill Coalition, a campaign started by the global advocacy group Ibis Reproductive Health which has pushed for over-the-counter (OTC) birth control, said the recommendation itself was a "landmark achievement for reproductive justice" and expressed hope that the panel's decision would result in swift approval by the FDA.
"Every day we wait is another day longer where barriers remain in place, preventing people from getting access to the contraceptive care they want and need," said the group. "It's past time for an OTC birth control pill that's fully covered by insurance, affordable, and available to people of all ages."
\u201cWe urge the @US_FDA to follow the committee's recommendation and approve an OTC progestin-only birth control pill WITHOUT any further delay.\u201d— Free the Pill (@Free the Pill) 1683739169
U.S. Rep. Ayanna Pressley (D-Mass.) also called on the FDA to take the advice of the panel "without delay," calling the recommendation "a major step forward in our fight to affirm folks' right to make decisions about their body, when to start a family, and their future."
The Free the Pill Coalition and other groups say OTC dispensing of birth control pills will increase access for people who have logistical or financial barriers to regularly seeing a doctor for a prescription.
Some FDA scientists told the panel that data from HRA Pharma raised concerns about whether people with certain medical conditions that contraindicate the use of OPill would follow warnings if the pill was available over-the-counter, and whether adolescents and people with limited literacy would follow the directions carefully enough to take the pill each day at the same time.
Author and MSNBC contributor Dr. Uché Blackstock called those concerns "quite paternalistic."
"Given the technology available, alternative ways can be developed to help deliver instructions," tweeted Blackstock.
Contrary to those claims, said Dr. Raegan McDonald-Mosley of the contraceptive advocacy group Power to Decide, "the committee followed the scientific evidence and paved the way for a massive breakthrough in access to birth control."
"As a practicing OB-GYN, I am confident that my patients do not need a visit with me to safely and effectively use the birth control pills they need," said McDonald-Mosley. "Requiring prescriptions and provider visits places unnecessary barriers to accessing reproductive health care, especially for those in contraceptive deserts—counties without a single clinic that provides the full range of contraceptive methods. In such areas, people have to travel further just to visit a provider to get their birth control, which means they need to take even more time off work or arrange for more childcare. Allowing OTC access for the pill would help eliminate these unnecessary barriers and increase access to reproductive health across the country."
Crediting the "tireless advocates, including the Free the Pill Coalition," with pressuring the FDA panel to take a significant step toward approving non-prescription use of OPill, NARAL Pro-Choice America said the decision is "not only historic—it is simply the right thing to do," particularly as abortion rights are under attack by right-wing lawmakers across the country.
"As reproductive freedom in our country faces an unprecedented crisis," said the group, "expanding access to proven, safe, and effective contraception has never been more important."
Keep ReadingShow Less
Most Popular